Lignowin 21.3mg Injection is indicated for the production of regional or local anaesthesia in case of surgeries or medical procedures. Also, it is indicated in the management of ventricular arrhythmias (abnormal heartbeat) associated with acute myocardial infarction, or cardiac surgery. Lignowin 21.3mg Injection blocks the influx (entry) of sodium ions into the membrane that surrounds the nerves, thereby preventing initiation and conduction of impulses and hence providing an anaesthetic effect. It blocks cardiac sodium channels, thereby treating arrhythmia.

FAQs

How does Lignowin 21.3mg Injection work?

Lignowin 21.3mg Injection blocks the influx (entry) of sodium ions into the membrane that surrounds the nerves, thereby preventing initiation and conduction of impulses and hence providing an anaesthetic effect. Lignowin 21.3mg Injection blocks cardiac sodium channels, thereby treats arrhythmia.

Does Lignowin 21.3mg Injection alter blood pressure?

Lignowin 21.3mg Injection may cause hypotension (low blood pressure) or hypertension (high blood pressure). Therefore, regular monitoring of blood pressure is advised whilst on treatment with Lignowin 21.3mg Injection.

Does Lignowin 21.3mg Injection cause nausea and vomiting?

Nausea and vomiting might be a side effect of Lignowin 21.3mg Injection. It is not necessary for everyone taking Lignowin 21.3mg Injection to experience these side effects. However, if the condition persists or worsens, please consult a doctor.

Does Lignowin 21.3mg Injection affect laboratory test results?

Lignowin 21.3mg Injection might increase creatinine phosphokinase levels. Therefore, if you are undergoing any tests, inform the person doing the tests that you have taken Lignowin 21.3mg Injection.